Literature DB >> 17320376

Reading the prognosis of the individual with breast cancer.

R W Blamey1, S E Pinder, G R Ball, I O Ellis, C W Elston, M J Mitchell, J L Haybittle.   

Abstract

AIM: To obtain better survival estimates for the individual than is provided by placement in an NPI group.
METHOD: Consecutive primary operable breast cancers treated at Nottingham City Hospital 1990-1999. Ten year % actuarial survivals plotted for 10 ranges of NPI from 2.0 to 6.9. There is an excellent inverse correlation between median NPI value for each range and survival at 10 years. To enable estimation of survival for all individual values of NPI, a curve fitting technique applied to these results (by G.B.) gave the formula to estimate survival from the individual's NPI score: 10 year % survival for the individual=-3.0079 x NPI(2)+12.30 x NPI+83.84. This gave an r(2) of 0.98. RESULTS AND
CONCLUSION: Greater accuracy in individual survival prediction is obtained by dividing women into 10 groups by NPI scores than in the originally described six groups; rank order of survival in relation to NPI score is preserved. A curve fitting technique has been applied to these data to give a formula for the prediction of 10 year survival for every 0.1 value of NPI.

Entities:  

Mesh:

Year:  2007        PMID: 17320376     DOI: 10.1016/j.ejca.2007.01.003

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  22 in total

1.  Is tumor cellularity in primary invasive breast carcinoma of prognostic significance?

Authors:  Emily S Reisenbichler; William Dupont; W Dale Plummer; Omar Hameed
Journal:  Virchows Arch       Date:  2017-04-19       Impact factor: 4.064

2.  A parsimonious 3-gene signature predicts clinical outcomes in an acute myeloid leukemia multicohort study.

Authors:  Sarah Wagner; Jayakumar Vadakekolathu; Sarah K Tasian; Heidi Altmann; Martin Bornhäuser; A Graham Pockley; Graham R Ball; Sergio Rutella
Journal:  Blood Adv       Date:  2019-04-23

Review 3.  Advancement of prognostic models in breast cancer: a narrative review.

Authors:  Ningning Min; Yufan Wei; Yiqiong Zheng; Xiru Li
Journal:  Gland Surg       Date:  2021-09

4.  Molecular risk assessment of BIG 1-98 participants by expression profiling using RNA from archival tissue.

Authors:  Janine Antonov; Vlad Popovici; Mauro Delorenzi; Pratyaksha Wirapati; Anna Baltzer; Andrea Oberli; Beat Thürlimann; Anita Giobbie-Hurder; Giuseppe Viale; Hans Jörg Altermatt; Stefan Aebi; Rolf Jaggi
Journal:  BMC Cancer       Date:  2010-02-09       Impact factor: 4.430

5.  Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK.

Authors:  H E Campbell; A M Gray; A L Harris; A H Briggs; M A Taylor
Journal:  Br J Cancer       Date:  2010-09-07       Impact factor: 7.640

6.  Molecular classification of breast cancer.

Authors:  Darina Vuong; Peter T Simpson; Benjamin Green; Margaret C Cummings; Sunil R Lakhani
Journal:  Virchows Arch       Date:  2014-05-31       Impact factor: 4.064

7.  One-stop diagnostic breast clinics: how often are breast cancers missed?

Authors:  P Britton; S W Duffy; R Sinnatamby; M G Wallis; S Barter; M Gaskarth; A O'Neill; C Caldas; J D Brenton; P Forouhi; G C Wishart
Journal:  Br J Cancer       Date:  2009-05-19       Impact factor: 7.640

8.  PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer.

Authors:  Gordon C Wishart; Elizabeth M Azzato; David C Greenberg; Jem Rashbass; Olive Kearins; Gill Lawrence; Carlos Caldas; Paul D P Pharoah
Journal:  Breast Cancer Res       Date:  2010-01-06       Impact factor: 6.466

9.  The Spatiotemporal Evolution of Lymph Node Spread in Early Breast Cancer.

Authors:  Peter Barry; Alexandra Vatsiou; Inmaculada Spiteri; Daniel Nichol; George D Cresswell; Ahmet Acar; Nicholas Trahearn; Sarah Hrebien; Isaac Garcia-Murillas; Kate Chkhaidze; Luca Ermini; Ian Said Huntingford; Hannah Cottom; Lila Zabaglo; Konrad Koelble; Saira Khalique; Jennifer E Rusby; Francesca Muscara; Mitch Dowsett; Carlo C Maley; Rachael Natrajan; Yinyin Yuan; Gaia Schiavon; Nicholas Turner; Andrea Sottoriva
Journal:  Clin Cancer Res       Date:  2018-06-11       Impact factor: 12.531

10.  PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2.

Authors:  G C Wishart; C D Bajdik; E Dicks; E Provenzano; M K Schmidt; M Sherman; D C Greenberg; A R Green; K A Gelmon; V-M Kosma; J E Olson; M W Beckmann; R Winqvist; S S Cross; G Severi; D Huntsman; K Pylkäs; I Ellis; T O Nielsen; G Giles; C Blomqvist; P A Fasching; F J Couch; E Rakha; W D Foulkes; F M Blows; L R Bégin; L J van't Veer; M Southey; H Nevanlinna; A Mannermaa; A Cox; M Cheang; L Baglietto; C Caldas; M Garcia-Closas; P D P Pharoah
Journal:  Br J Cancer       Date:  2012-07-31       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.